Avanos MedicalAVNS +0.08%62 Net Margin % is 2.80% as of Mar. 2026. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.43 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Avanos Medical ranks worse than 64.38% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Avanos Medical's Net Income for the
three
months ended in Mar. 2026 was $5.1 Mil. Avanos Medical's Revenue for the
three
months ended in Mar. 2026 was $182.2 Mil. Therefore, Avanos Medical's net margin for the quarter that ended in Mar. 2026 was 2.80%.
The historical rank and industry rank for Avanos Medical's Net Margin % or its related term are showing as below:
AVNS'
s Net Margin % Range Over the Past 10 Years
Min: -57.01 Med: -1.37 Max: 12.97
Current: -10.39
AVNS's Net Margin % is ranked worse than 64.38% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs AVNS: -10.39
Avanos Medical (NYSE:AVNS) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Avanos Medical Net Margin % Related Terms
Avanos Medical Net Margin % Historical Data
* Premium members only.
The historical data trend for Avanos Medical's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Avanos Medical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Net Margin % distribution charts can be found below:
* The bar in red indicates where Avanos Medical's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical (AVNS) has a Net Margin % of 2.80% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Avanos Medical and its competitors. According to the industry distribution chart, Avanos Medical ranks #526 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 64.4%.
Is Avanos Medical's Net Margin % too high?
Avanos Medical's current Net Margin % is 2.80%. The Medical Devices & Instruments industry median Net Margin % is 2.07. Avanos Medical's value of 2.80% is 35.3% above this industry median. Based on the distribution chart, Avanos Medical ranks #526 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Net Margin % compare to IRMD and TNDM?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #526 out of 817 companies for Net Margin %. This places Avanos Medical in the lower half of its industry. The industry median Net Margin % is 2.07. Avanos Medical's value of 2.80% is 35.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avanos Medical's current Net Margin % of 2.80% is 35.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Avanos Medical and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current Net Margin % is 2.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.43, compared to a current price of $24.95 — trading 28.4% above its estimated fair value. The current Net Margin % is 2.80% and 35.3% above the Medical Devices & Instruments industry median of 2.07. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Net Margin % is 2.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.95 is trading 28.4% above its estimated GF Value™ of $19.43.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
Net Margin %: 2.80%
GF Value™: $19.43 vs. price of $24.95 (28.4% above fair value)
Industry Position: 35.3% above the Medical Devices & Instruments median (#526 of 817)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
